Trial description:
‘ARTIST’ stands for a translational research Approach to development of optimal Renal cancer Treatments In Surgical and systemic Therapy patients, a single-centre translational research study designed to identify and characterize novel biomarkers for the optimal detection, monitoring and treatment of renal cell cancer (RCC).
Contact name:
Dr James Jones
Trial start date:
Monday, January 4, 2021
Trial end date:
Wednesday, December 31, 2025
Trial tumour type:
Kidney
